Abbott’s Navitor TAVI Gets CE Mark for Expanded Use to Treat More People With Aortic Stenosis
August 29, 2025
Navitor is now approved as a minimally invasive alternative to surgery for patients in Europe with symptomatic, severe aortic stenosis (a common and life-threatening heart valve disease)